Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

<p>Phosphoproteins</p>

שמור ב:
מידע ביבליוגרפי
מחבר ראשי: Xiaoqing Cheng (16918496) (author)
מחברים אחרים: Yirui Sun (16918499) (author), Maureen Highkin (16918502) (author), Nagalaxmi Vemalapally (16918505) (author), Xiaohua Jin (16918508) (author), Brandon Zhou (16918511) (author), Julie L. Prior (16918514) (author), Ashley R. Tipton (16918517) (author), Shunqiang Li (15123195) (author), Anton Iliuk (16918520) (author), Samuel Achilefu (11605234) (author), Ian S. Hagemann (15026769) (author), John R. Edwards (16918523) (author), Ron Bose (15045749) (author)
יצא לאור: 2025
נושאים:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Methods and Technology
Biological Agents & Therapies
Antibody-drug conjugates
Antireceptors
Breast Cancer
Cell Cycle
CDKs and CDK inhibitors
Preclinical Models
Organoids
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
תיאור
סיכום:<p>Phosphoproteins</p>

פריטים דומים